ArticleScandinavian journal of trauma, resuscitation and emergency medicine2026
Prophylaxis of opioid-induced nausea in helicopter emergency medical service: a prospective quasi-experimental study.
Article in Scandinavian journal of trauma, resuscitation and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIn prehospital emergency medicine, opioids are usually used to treat acute traumatic pain. A common side effect of opioids is nausea. To prevent this, the prophylactic administration of 5-HT
methodsPatients over the age of 16 who received opioid therapy due to acute traumatic pain by the crews of a total of six HEMS bases between February 2024 and April 2025 were prospectively included. Nausea prophylaxis after opioid-based pain therapy was performed according to a fixed rotating 7-day schedule: no nausea prophylaxis, medication-based nausea prophylaxis with ondansetron 4 mg intravenously, and aromatherapy-based nausea prophylaxis by inhalation of isopropanol. A nausea score was evaluated at the time of opioid administration and upon handover at the destination hospital, using a numeric rating scale (NRS) between 0 (no nausea) and 10 (maximum nausea). Primary endpoint was the change in NRS between the time before opioid administration and the time of patient handover at the emergency department. Secondary endpoints were incidence of moderate and severe nausea (defined as an NRS > 3), the incidence of vomiting during prehospital patient care and need of rescue medication (ondansetron for therapeutic use).
resultsA total of 205 patients were included in the analysis. Eighty-six in the "no prophylaxis" group, 64 in the ondansetron group, and 55 in the aromatherapy group. We found a median change in NRS of 0 (interquartile range 0-0) points across all groups. An increase in NRS was observed in 15% of patients in the no prophylaxis group, 14% in the ondansetron group, and 15% in the aromatherapy group. An NRS > 3 was observed in 14% of patients in the no prophylaxis group and in 11% of patients in both the ondansetron and aromatherapy groups. Vomiting occurred in 4% of patients in the no prophylaxis group, 2% in the ondansetron group, and in none of the aromatherapy group. Therapeutic administration of ondansetron was necessary in 4 patients in the "no prophylaxis" group and in one patient in the aromatherapy group. None of the patients experienced any improvement in nausea as a result, three of these patients from the "no prophylaxis" group vomited after ondansetron administration.
conclusionNeither the prophylactic administration of ondansetron nor aromatherapy seem to be beneficial for the prevention of opioid-induced nausea in unselected patients in the setting of prehospital emergency medicine. Larger randomized controlled trials are needed to clarify whether certain subgroups may benefit.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.